Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Urinary Tract Infections D014552 11 associated lipids
Urticaria D014581 13 associated lipids
Vertigo D014717 4 associated lipids
Vomiting D014839 21 associated lipids
Whooping Cough D014917 6 associated lipids
Wound Infection D014946 12 associated lipids
Yaws D015001 4 associated lipids
Superinfection D015163 3 associated lipids
Sexually Transmitted Diseases, Bacterial D015231 5 associated lipids
Mycobacterium avium-intracellulare Infection D015270 4 associated lipids
Dry Eye Syndromes D015352 10 associated lipids
Weight Gain D015430 101 associated lipids
Weight Loss D015431 56 associated lipids
Ethmoid Sinusitis D015521 2 associated lipids
Frontal Sinusitis D015522 1 associated lipids
Corneal Edema D015715 3 associated lipids
Erythema Chronicum Migrans D015787 3 associated lipids
Uveitis, Intermediate D015867 3 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Helicobacter Infections D016481 21 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Purpura, Thrombocytopenic, Idiopathic D016553 4 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Pneumocystis Infections D016720 1 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Ureaplasma Infections D016869 5 associated lipids
Neisseriaceae Infections D016870 3 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Common Variable Immunodeficiency D017074 4 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Pelvic Pain D017699 7 associated lipids
Community-Acquired Infections D017714 8 associated lipids
Granuloma, Pyogenic D017789 2 associated lipids
Furcation Defects D017823 1 associated lipids
T-Lymphocytopenia, Idiopathic CD4-Positive D018344 1 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Parasitemia D018512 5 associated lipids
Abdominal Abscess D018784 2 associated lipids
Gingival Overgrowth D019214 7 associated lipids
Pseudolymphoma D019310 1 associated lipids
Pouchitis D019449 3 associated lipids
Syncope, Vasovagal D019462 1 associated lipids
Acquired Hyperostosis Syndrome D020083 1 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Focal Nodular Hyperplasia D020518 1 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Tkadlec J et al. Characterization of Staphylococcus aureus Strains Isolated from Czech Cystic Fibrosis Patients: High Rate of Ribosomal Mutation Conferring Resistance to MLS(B) Antibiotics as a Result of Long-Term and Low-Dose Azithromycin Treatment. 2015 Microb. Drug Resist. pmid:25826283
Weinberger M et al. Diffuse panbronchiolitis in a 10-year-old boy. 2015 Pediatr. Pulmonol. pmid:25824890
Dave J and Sefton A Enteric fever and its impact on returning travellers. 2015 Int Health pmid:25808163
Li X et al. Preparation and characterization of azithromycin--Aerosil 200 solid dispersions with enhanced physical stability. 2015 Int J Pharm pmid:25794608
da Cunha Filho RR et al. Acute generalized exanthematous pustulosis by azithromycin. 2015 Int. J. Dermatol. pmid:25784092
Bala M et al. Trends of resistance to antimicrobials recommended currently and in the past for management of gonorrhea in the Apex STD center in India and comparison of antimicrobial resistance profile between 2002-2006 and 2007-2012. 2015 Sex Transm Dis pmid:25763675
Laopaiboon M et al. Azithromycin for acute lower respiratory tract infections. 2015 Cochrane Database Syst Rev pmid:25749735
Moi H et al. Spontaneous Regression of Untreatable Mycoplasma genitalium Urethritis. 2015 Acta Derm. Venereol. pmid:25634824
Hicks LA et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. 2015 Clin. Infect. Dis. pmid:25747410
Ghinai R et al. A cross-sectional study of 'yaws' in districts of Ghana which have previously undertaken azithromycin mass drug administration for trachoma control. 2015 PLoS Negl Trop Dis pmid:25632942
Walsh MS et al. Prevalence of Chlamydia trachomatis infection in Samoan women aged 18 to 29 and assessment of possible risk factors: a community-based study. 2015 Trans. R. Soc. Trop. Med. Hyg. pmid:25732755
Hamasuna R et al. The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013. 2015 J. Infect. Chemother. pmid:25727286
Gershengorn HB et al. The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia. 2015 Clin. Infect. Dis. pmid:25722195
Pettus K et al. In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae. 2015 Antimicrob. Agents Chemother. pmid:25624328
Hildebrand F et al. Efficacy of gamithromycin for the treatment of foals with mild to moderate bronchopneumonia. 2015 J. Vet. Intern. Med. pmid:25619521
Denlinger CE Matrix metalloproteinases and bronchiolitis obliterans: Wrapping the enigma in a riddle. 2015 J. Thorac. Cardiovasc. Surg. pmid:25618413
Khosropour CM et al. Efficacy of standard therapies against Ureaplasma species and persistence among men with non-gonococcal urethritis enrolled in a randomised controlled trial. 2015 Sex Transm Infect pmid:25616607
Liu Y et al. Can tetracycline antibiotics duplicate the ability of azithromycin to stimulate human meibomian gland epithelial cell differentiation? 2015 Cornea pmid:25611398
Chen M et al. Azithromycin attenuates cigarette smoke extract-induced oxidative stress injury in human alveolar epithelial cells. 2015 Mol Med Rep pmid:25607112
Sutton AL et al. Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis. 2015 Am. J. Obstet. Gynecol. pmid:25595580
Krenn K et al. Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans. 2015 J. Thorac. Cardiovasc. Surg. pmid:25595376
Unger HW et al. Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial. 2015 BMC Med pmid:25591391
Valcanis M et al. Outbreak of locally acquired azithromycin-resistant Shigella flexneri infection in men who have sex with men. 2015 Pathology pmid:25474524
Rihani FB Azithromycin and congenital heart disease. 2015 Int J Oral Maxillofac Surg pmid:25444481
Dey S et al. In Vitro Anti-inflammatory and Immunomodulatory Effects of Ciprofloxacin or Azithromycin in Staphylococcus aureus-Stimulated Murine Macrophages are Beneficial in the Presence of Cytochalasin D. 2015 Inflammation pmid:25429758
Fraser LA et al. Calcium channel blocker-clarithromycin drug interaction did not increase the risk of nonvertebral fracture: a population-based study. 2015 Ann Pharmacother pmid:25429094
Solleti VS et al. Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients. 2015 J. Antimicrob. Chemother. pmid:25416744
Chou HW et al. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study. 2015 Clin. Infect. Dis. pmid:25409476
Bauquier JR et al. Anti-inflammatory effects of four potential anti-endotoxaemic drugs assessed in vitro using equine whole blood assays. 2015 J. Vet. Pharmacol. Ther. pmid:25407884
Jeong BH et al. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. 2015 Am. J. Respir. Crit. Care Med. pmid:25393520
Bissessor M et al. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection. 2015 Clin. Infect. Dis. pmid:25371490
Chi KH et al. Molecular differentiation of Treponema pallidum subspecies in skin ulceration clinically suspected as yaws in Vanuatu using real-time multiplex PCR and serological methods. 2015 Am. J. Trop. Med. Hyg. pmid:25404075
Merchan LM et al. Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization. 2015 Antimicrob. Agents Chemother. pmid:25385115
Nonaka L et al. Novel macrolide-resistance genes, mef(C) and mph(G), carried by plasmids from Vibrio and Photobacterium isolated from sediment and seawater of a coastal aquaculture site. 2015 Lett. Appl. Microbiol. pmid:25765542
Cocco G and Jerie P Torsades de pointes induced by the concomitant use of ivabradine and azithromycin: an unexpected dangerous interaction. 2015 Cardiovasc. Toxicol. pmid:25158669
Kashkouli MB et al. Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double-masked open-label clinical trial. 2015 Br J Ophthalmol pmid:25138765
Gundevia Z et al. Positivity at test of cure following first-line treatment for genital Mycoplasma genitalium: follow-up of a clinical cohort. 2015 Sex Transm Infect pmid:25096921
Hussain S et al. N-acetylcysteine and azithromycin affect the innate immune response in cystic fibrosis bronchial epithelial cells in vitro. 2015 Exp. Lung Res. pmid:25058850
Sandrock CE and Norris A Infection in severe asthma exacerbations and critical asthma syndrome. 2015 Clin Rev Allergy Immunol pmid:24984968
Aucamp M et al. Amorphous azithromycin with improved aqueous solubility and intestinal membrane permeability. 2015 Drug Dev Ind Pharm pmid:24980913
Martinez MA et al. Clinical and histologic features of azithromycin-induced liver injury. 2015 Clin. Gastroenterol. Hepatol. pmid:25111234
Cabeza J et al. Feasibility of Chlamydia trachomatis screening and treatment in pregnant women in Lima, Peru: a prospective study in two large urban hospitals. 2015 Sex Transm Infect pmid:25107711
Ratjen F et al. Response to letter. 2015 Pediatr. Pulmonol. pmid:24700677
Tayob N and Murray S Nonparametric tests of treatment effect based on combined endpoints for mortality and recurrent events. 2015 Biostatistics pmid:24719282
Salman S et al. Pharmacokinetics of Transfer of Azithromycin into the Breast Milk of African Mothers. 2015 Antimicrob. Agents Chemother. pmid:26711756
Geisler WM et al. Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection. 2015 N. Engl. J. Med. pmid:26699167
Smith C et al. Use and safety of azithromycin in neonates: a systematic review. 2015 BMJ Open pmid:26656010
Solomon AW et al. Trachoma and Yaws: Common Ground? 2015 PLoS Negl Trop Dis pmid:26633176
Ruíz del Olmo I et al. [Severe neutropenia as side effect of medical treatment in nontuberculous mycobacterial adenitis]. 2015 Rev Chilena Infectol pmid:26633119
Woodruff AE et al. Azithromycin-Induced, Biopsy-Proven Acute Interstitial Nephritis in an Adult Successfully Treated with Low-Dose Corticosteroids. 2015 Pharmacotherapy pmid:26598102
Jensen EA et al. Evidence-Based Pharmacologic Therapies for Prevention of Bronchopulmonary Dysplasia: Application of the Grading of Recommendations Assessment, Development, and Evaluation Methodology. 2015 Clin Perinatol pmid:26593077
Fan WG et al. Male Paraurethral Duct Infection and Subsequent Paraurethral Duct Dilation. 2015 Chin. Med. J. pmid:26608997
Wise J Early use of azithromycin may reduce severity of wheezing, study finds. 2015 BMJ pmid:26582751
Maračić S et al. 1,2,3-Triazole pharmacophore-based benzofused nitrogen/sulfur heterocycles with potential anti-Moraxella catarrhalis activity. 2015 Bioorg. Med. Chem. pmid:26578325
Zhang B et al. Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury. 2015 J Neuroinflammation pmid:26597676
Cohen RT and Pelton SI Individual Benefit vs Societal Effect of Antibiotic Prescribing for Preschool Children With Recurrent Wheeze. 2015 JAMA pmid:26575058
Roca A et al. Prevention of bacterial infections in the newborn by pre-delivery administration of azithromycin: Study protocol of a randomized efficacy trial. 2015 BMC Pregnancy Childbirth pmid:26585192
Bacharier LB et al. Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial. 2015 JAMA pmid:26575060
Trembizki E et al. Direct real-time PCR-based detection of Neisseria gonorrhoeae 23S rRNA mutations associated with azithromycin resistance. 2015 J. Antimicrob. Chemother. pmid:26338048
Pollock E and Hasse B [CME. Pertussis]]. 2015 Praxis (Bern 1994) pmid:26331198
Xue J et al. Occurrence of high-level azithromycin-resistant Neisseria gonorrhoeae isolates in China. 2015 J. Antimicrob. Chemother. pmid:26316384
Jensen JS and Bradshaw C Management of Mycoplasma genitalium infections - can we hit a moving target? 2015 BMC Infect. Dis. pmid:26286546
McCallum GB et al. Further clinical trials on macrolides for bronchiolitis in infants are unnecessary. 2015 J. Allergy Clin. Immunol. pmid:26316096
Pavlova A and Gumbart JC Parametrization of macrolide antibiotics using the force field toolkit. 2015 J Comput Chem pmid:26280362
Puri K et al. Bartonella Osteomyelitis of the Acetabulum: Case Report and Review of the Literature. 2015 Vector Borne Zoonotic Dis. pmid:26273806
Beigelman A and Bacharier LB Reply: To PMID 25458910. 2015 J. Allergy Clin. Immunol. pmid:26309182
Marks M et al. Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws. 2015 PLoS Negl Trop Dis pmid:26241484
Stellari F et al. In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin. 2015 J Transl Med pmid:26239109
Taylor SP et al. Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly. 2015 Am. J. Med. pmid:26291905
Haruki Y et al. [Investigation of Intravenous Azithromycin Treatment Safety When Reducing Solvent for Intensive Care Unit Patients]. 2015 Yakugaku Zasshi pmid:26234357
Wetherbee EE et al. Self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. 2015 Int J Chron Obstruct Pulmon Dis pmid:26229455
Moi H et al. Management of non-gonococcal urethritis. 2015 BMC Infect. Dis. pmid:26220178
Kong FY and Hocking JS Treatment challenges for urogenital and anorectal Chlamydia trachomatis. 2015 BMC Infect. Dis. pmid:26220080
Å majs D et al. Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains? 2015 Am. J. Trop. Med. Hyg. pmid:26217043
Beigelman A et al. Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis? 2015 J. Allergy Clin. Immunol. pmid:26215052
Pereira A et al. Acute onset of widespread pustular eruption. 2015 Aust Fam Physician pmid:26209988
Tabidze IL et al. Adherence to Centers for Disease Control and Prevention Gonococcal Treatment Guidelines Among Chicago Health Care Providers, 2011-2012. 2015 Sex Transm Dis pmid:26165433
Kirby A Comment on: Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data. 2015 J. Antimicrob. Chemother. pmid:26157112
Furfaro LL et al. In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin. 2015 Int. J. Antimicrob. Agents pmid:26141231
Farber FR et al. Atraumatic splenic rupture from Babesia: A disease of the otherwise healthy patient. 2015 Ticks Tick Borne Dis pmid:26123434
Ahmed N et al. Donovanosis causing lymphadenitis, mastoiditis, and meningitis in a child. 2015 Lancet pmid:26122163
Barni S et al. Azithromycin is more allergenic than clarithromycin in children with suspected hypersensitivity reaction to macrolides. 2015 J Investig Allergol Clin Immunol pmid:25997306
Jo KW et al. The efficacy of prophylactic azithromycin on bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. 2015 Int. J. Hematol. pmid:26121954
Earl CS et al. Haemophilus influenzae responds to glucocorticoids used in asthma therapy by modulation of biofilm formation and antibiotic resistance. 2015 EMBO Mol Med pmid:25995336
Koepke R et al. Widespread Bordetella parapertussis Infections-Wisconsin, 2011-2012: Clinical and Epidemiologic Features and Antibiotic Use for Treatment and Prevention. 2015 Clin. Infect. Dis. pmid:26113655
Hoffmann K et al. Prevalence and resistance patterns of commensal S. aureus in community-dwelling GP patients and socio-demographic associations. A cross-sectional study in the framework of the APRES-project in Austria. 2015 BMC Infect. Dis. pmid:25981559
Qin YH et al. Transdermal application of azithromycin-amlodipine-heparin gel enhances survival of infected random ischaemic flap. 2015 J Plast Surg Hand Surg pmid:26083309
Lietman TM et al. The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing. 2015 Epidemics pmid:25979286
Missov E and Cogswell R Sudden cardiac death, mitral valve prolapse, and long QT syndrome. 2015 Am. J. Med. pmid:26071830
Buset SL et al. Non-surgical periodontal therapy supplemented with systemically administered azithromycin: a systematic review of RCTs. 2015 Clin Oral Investig pmid:26063646
Hauser G et al. Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial. 2015 Medicine (Baltimore) pmid:25929897
Yin SM et al. Disseminated Mycobacterium kansasii disease in complete DiGeorge syndrome. 2015 J. Clin. Immunol. pmid:26048260
Craig AP et al. Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract. 2015 BMC Infect. Dis. pmid:25925662
Cusini M Therapy for Gonococcal and Non-gonococcal Genital Infections is a Major Problem for Clinicians. 2015 Acta Derm. Venereol. pmid:25917593
Harding-Esch E et al. Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study. 2015 PLoS Negl Trop Dis pmid:25901349
Rudoler N et al. Comparison of the acute phase protein and antioxidant responses in dogs vaccinated against canine monocytic ehrlichiosis and naive-challenged dogs. 2015 Parasit Vectors pmid:25888870
Chandra R et al. Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study. 2015 Malar. J. pmid:25881046
Schroeck JL et al. Factors associated with antibiotic misuse in outpatient treatment for upper respiratory tract infections. 2015 Antimicrob. Agents Chemother. pmid:25870064
Verleden GM et al. Current views on chronic rejection after lung transplantation. 2015 Transpl. Int. pmid:25857869
Waites KB et al. In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas. 2015 Antimicrob. Agents Chemother. pmid:25824220